Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors by Carly R. Cabel, Carly R. Cabel, Briana A. Guzman, Elaheh Alizadeh, Elaheh Alizadeh, Elaheh Alizadeh, Shuaizhi Li, Cameron Holberg, Chonlarat Wichaidit, Darren A. Cusanovich, Darren A. Cusanovich, Darren A. Cusanovich, Andrew L. Paek, Andrew L. Paek, Gregory R. J. Thatcher, Koenraad Van Doorslaer, Koenraad Van Doorslaer, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, James E. Crowe, James E. Crowe, James E. Crowe, Robert H. Carnahan, Robert H. Carnahan, Samuel K. Campos, Samuel K. Campos, Curtis A. Thorne, Curtis A. Thorne

Get full text